BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17397922)

  • 1. Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells.
    Yang SH; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
    Leuk Res; 2007 Oct; 31(10):1413-20. PubMed ID: 17397922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
    Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
    Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
    Yang SH; Chien CM; Su JC; Chen YL; Chang LS; Lin SR
    J Biochem Mol Toxicol; 2008; 22(6):396-404. PubMed ID: 19111001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by cardiotoxin III (Naja naja atra) in K562 leukemia cells.
    Yang SH; Chien CM; Chang LS; Lin SR
    Toxicon; 2007 Jun; 49(7):966-74. PubMed ID: 17368702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells.
    Chien CM; Yang SH; Lin KL; Chen YL; Chang LS; Lin SR
    Chem Biol Interact; 2008 Oct; 176(1):40-7. PubMed ID: 18638462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL; Kuo PL; Lin LT; Lin CC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
    Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
    Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel indoloquinoline derivative, IQDMA, induces S-phase arrest and apoptosis in promyelocytic leukemia HL-60 cells.
    Hu XW; Chien CM; Yang SH; Lin YH; Lu CM; Chen YL; Lin SR
    Cell Biol Toxicol; 2006 Nov; 22(6):417-27. PubMed ID: 16906476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells.
    Moon DO; Kim MO; Choi YH; Kim ND; Chang JH; Kim GY
    Cancer Lett; 2008 Jun; 264(2):316-25. PubMed ID: 18343029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells.
    Lee SJ; Moon GS; Jung KH; Kim WJ; Moon SK
    Food Chem Toxicol; 2010 Jan; 48(1):277-83. PubMed ID: 19833164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
    Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J
    Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of 2-methoxyestradiol-induced apoptosis and G2/M cell-cycle arrest of nasopharyngeal carcinoma cells.
    Lee YM; Ting CM; Cheng YK; Fan TP; Wong RN; Lung ML; Mak NK
    Cancer Lett; 2008 Sep; 268(2):295-307. PubMed ID: 18492602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Biochem; 2010 Jan; 109(1):245-54. PubMed ID: 19937732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
    Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
    Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells.
    Lee SJ; Kim SK; Choi WS; Kim WJ; Moon SK
    Arch Biochem Biophys; 2009 Oct; 490(2):103-9. PubMed ID: 19733546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
    Yu C; Rahmani M; Dent P; Grant S
    Exp Cell Res; 2004 May; 295(2):555-66. PubMed ID: 15093752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
    Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
    Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes.
    Lee YJ; Shukla SD
    Eur J Pharmacol; 2005 Jan; 508(1-3):31-45. PubMed ID: 15680252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.